Archive
Original product demo
This MP4 walkthrough shows the older product version I built. The company exists today at evorad.com, but its current product line has evolved from that original version.
Kostas KarolemeasEvorad S.A.
Evorad
2006 - 2011 / Co-founder, CEO, CTO
Product challenge
The current Evorad product has evolved since my time there. The version I built aimed to make clinical workflow, advanced visualization, remote collaboration, and certification feel like one dependable product for radiology teams.
Evorad exists today, but the product shown on its website has evolved and is similar rather than identical to the version I built.
Product pillars
RIS-PACS
radiology workflow and imaging platform
2D / 3D
advanced diagnostic visualization
ISO 13485
medical device quality management
CE IIa
medical software certification class
Leadership scope and key decisions
I took on company, product, technology, architecture, and hands-on implementation responsibilities while building a comprehensive RIS-PACS solution for enterprise radiology operations.
I led development across advanced 2D and 3D medical imaging, diagnostic visualization, image processing, and the broader visual-computing stack required for clinical use.
I led certification work for ISO 9001, ISO 13485, and CE Mark Class IIa for medical software.
I prototyped cloud and web-based telemedicine workflows for secure medical image sharing and remote collaboration with Java EE, Tomcat, MySQL, Amazon EC2/RDS/S3, HTML5, JavaScript, iOS, and Linux.
Evidence and lasting outcomes
A certified medical imaging product with operational, clinical, and regulatory discipline.
A deep base in advanced visualization, image processing, 3D medical imaging, and the pressure of clinical workflow complexity.
A telemedicine-oriented foundation for remote image sharing and distributed radiology collaboration.
A durable pattern for me: product leadership grounded in the technical and regulatory details.
Contact
Let's talk about what you're building next.
I welcome conversations about ambitious AI products, selected advisory collaborations, and speaking invitations. I'm also open to confidential conversations about unusually strong leadership opportunities.